TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

CSF1R Inhibition with Chemotherapy Relieves Systemic Immune Suppression in Patients with Metastatic Triple-Negative Breast Cancer and Boosts Anti-PD-1 Efficacy in Transgenic Mammary Tumors.

Amanda Poissonnier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.